© 2023 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Naltrexone

Only 1 in 5 U.S. Adults With Opioid Use Disorder Received Medications to Treat it in 2021

NIH and CDC study finds telehealth associated with increased likelihood of receiving evidence-based standard of care.

Recovery From Addiction Is a Journey. There’s No One-and-Done Solution.

Addiction is a chronic illness requiring constant vigilance, and relapses are part of the journey to recovery.

Combination Therapy for Methamphetamine Use Found to Be Effective for Some

The drugs naltrexone and bupropion are currently approved for other indications.

Primary Care Docs Not Keen to Prescribe Opioid Use Disorder Treatment

A national survey found that primary care physicians had little interest in prescribing buprenorphine or naltrexone.

People With History of Injecting Drugs Should Not Be Denied Hepatitis C Treatment

A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.

More Research Is Needed to Guide Response to Rural Opioid Crisis

Researchers found critical gaps in the scientific knowledge about the opioid epidemic.

Treat Opioid Addiction, Prevent Hep C Reinfection

Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.

Teens May Benefit From Meds to Treat Opioid Use Disorder

A literature review shows promising signs that teenagers, like adults, can benefit from methadone, buprenorphine and naltrexone.

Treatment for Opioid Addiction Is Tied to a Low Hep C Reinfection Rate

Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.

It’s About Time Clinicians Stepped Up to Treat Opioid Addiction

A group of experts has issued a call to arms, spotlighting missed opportunities for addiction treatment in hospital settings.
The opening session of CROI 2018 in Boston.

The Best of CROI 2018

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
Advertisement

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.